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Abstract
The molecular defects in the catalase gene, levels of m-RNA and properties of the resid-
ual catalase studied by scientists are reviewed in human (Japanese, Swiss and Hungarian) and
non-human (mouse and beagle dog) acatalasemia with reference to the bioinformatics. Japanese
acatalasemia-I, the G to A transition at the fifth position of intron 4 of the catalase gene, limited the
correct splicing of the mRNA and synthesized trace catalase with normal properties. Hungarian
acatalasemia type C showed a splicing mutation. In the Japanese acatalasemia II and the type A
and B of Hungarian acatalasemia, the deletion or insertion of nucleotides was observed in the cod-
ing regions, and the frame shift altered downstream amino acid sequences and formed truncated
proteins. In the Hungarian acatalasemia D, the substitution of a nucleotide in the exon was found.
In mouse and beagle dog acatalasemia, the substitution of nucleotides in the coding regions was
also observed. Studies of residual catalase in Swiss, mouse and beagle dog acatalasemia showed
that aberrant catalase protein degrades more quickly than normal catalase in cells. The experimen-
tal research in genetic toxicology concerning the effect of oxidative stressors (nitrogen monoxide,
nitrogen dioxide and so on) on Japanese acatalasemic blood and acatalasemic mice is described.
The clinical features of Japanese and Hungarian acatalasemic subjects are also described.
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The molecular defects in the catalase gene,  levels of m-RNA and properties of the residual catalase 
studied by scientists are reviewed in human (Japanese,  Swiss and Hungarian) and non-human (mouse 
and beagle dog) acatalasemia with reference to the bioinformatics.  Japanese acatalasemia-I,  the G to 
A transition at the ﬁfth position of intron 4 of the catalase gene,  limited the correct splicing of the 
mRNA and synthesized trace catalase with normal properties.  Hungarian acatalasemia type C showed 
a splicing mutation.  In the Japanese acatalasemia II and the type A and B of Hungarian acatalasemia,  
the deletion or insertion of nucleotides was observed in the coding regions,  and the frame shift altered 
downstream amino acid sequences and formed truncated proteins.  In the Hungarian acatalasemia D,  
the substitution of a nucleotide in the exon was found.  In mouse and beagle dog acatalasemia,  the 
substitution of nucleotides in the coding regions was also observed.  Studies of residual catalase in 
Swiss,  mouse and beagle dog acatalasemia showed that aberrant catalase protein degrades more 
quickly than normal catalase in cells.  The experimental research in genetic toxicology concerning the 
eﬀect of oxidative stressors (nitrogen monoxide,  nitrogen dioxide and so on) on Japanese acatalasemic 
blood and acatalasemic mice is described.  The clinical features of Japanese and Hungarian acatalas-
emic subjects are also described.
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Catalase Enzyme
　 In almost all aerobic organisms, hydrogen peroxide       
is produced by normal metabolic process,  mostly from 
superoxide by superoxide dismutase,  and then is bro-
ken down by the catalase.  The peroxidative reaction 
is remarkable at low hydrogen peroxide concentra-
tions,  but the catalatic reaction is predominant at 
higher hydrogen peroxide concentrations.  Human 
catalase with a molecular mass of 24,000 is a tetramer 
comprised of 4 identical subunits,  each of which con-
sists of 526 amino acid residues [1].
History and Research Process in Human and 
Non-human Acatalasemia
　 1. Human acatalasemia.
　 1) Japanese acatalasemia: Acatalasemia was ﬁrst     
described by the Shigeo Takahara in Japan in 1947 
[2,  3].  Takahara described that an 11ﾝyear-old pale 
looking girl came to the Department of Ear,  Nose,  
and Throat Outpatient Clinic in Okayama University 
Medical School with high fever and complained of 
severe oral ulcer in 1946.  After a radical operation,  
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Takahara poured hydrogen peroxide on the wound and 
found that the blood immediately turned a brownish-
black and the usual bubbles did not appear.  Four out 
of 7 siblings had mouth gangrene,  and all of their 
blood reacted with hydrogen peroxide in the same 
manner,  indicating a genetic abnormality [4].  This 
oral gangrene due to acatalasemia was called 
Takaharaʼs disease.  Takahara also found that the 
heterozygote of acatalasemia had catalase activity in 
the blood,  though its amounts were one half catalase 
activities of normal person and designated as “hypo-
catalasemia” [5].  He carried out a large-scale survey 
of hypocatalasemia in Japanese,  Korean and Chinese 
individuals,  and the diﬀerence in the frequency of 
acatalasemic genes among the races of the Far East 
area was reported [5,  6].  The properties of residual 
catalase were also described [4].
　 2) Swiss acatalasemia: Acatalasemia was described     
by Hugo Aebi [7ﾝ10].  Aebi reported that it was 
impossible to distinguish normal and heterozygous 
individuals based on blood catalase activity [10].
 3) Hungarian acatalasemia: Two sisters of a      
Hungarian family were found to be the type A of 
acatalasemic subjects by Góth in 1992 [11,  12].  The 
blood catalase activities of the acatalasemic A subjects 
were 4.0 and 6.7ｵ of normal activity [12],  and the 
activity of hypocatalasemias in the family was 45.8ｵ 
of normal.  The higher incidence of diabetes mellitus 
in Hungarian catalase deﬁcient family members was 
reported by Góth [13].
　 4) Peruvian and German acatalasemia: Propositus     
of acatalasemia was found via a progressive oral gan-
grene called Takaharaʼs disease and via a hydrogen 
peroxide test of the blood in 1979 in Peru [14] and in 
1999 in Germany [15].
　 5) Jewish acatalasemia: Iranian born Jewish origin      
with acatalasemia (7～9ｵ of normal) and with glu-     
cose-6-dehydregenase deﬁciency were found by 
Szeinberg [16]. 
　 2. Non-human acatalasemia.
　 1) Mouse acatalasemia: Acatalasemic mice (Cs    b) 
and homologous hypocatalasemic mice (Csc) were pro-
duced by Feinstein in 1969 by hybridizing mice with 
low catalase activity [17],  which were induced by 
X-ray irradiation,  and the Csb and Csc genes were 
transferred into the genes of C3H strain mice.  The 
C3H/AnL Csb (male),  C3H/Anl Csb (female) mice,  
C3H/AnL Csc and C3H/Anl Csc mice along with wild-
type mice were donated from Argonne National 
Laboratory to Ogata for collaborative research by 
courtesy of Feinstein (1979).
　 2) Beagle dog acatalasemia: Spontaneous occur-    
rence of acatalasemic beagle dog occasionally express-
ing signs of Takaharaʼs disease was reported by 
Fukuda in 1982 [18].
　 Review: A review describing a comparison among      
Japanese and Swiss acatalasemia in humans and acata-
lasemic mice was described by Ogata in 1991 [19].  
The characterization and comparison of Hungarian 
acatalasemia to the Japanese and Swiss acatalasemia 
were performed by Góth in 2001 [20] and 2004 
[13].
Characterization of Acatalasemia and 
Hypocatalasemia
　 1. Acatalasemia. Takahara deﬁned acatalase-
mia as a new term meaning “a deﬁciency of catalase 
enzyme. ” The Japanese type of acatalasemia is a rare 
genetic abnormality deﬁned by an apparent lack of 
catalase enzyme.  About half of acatalasemia originates 
from ulcerating oral gangrenes; this type is called 
Takaharaʼs disease [4,  6].  Japanese acatalasemia is 
inherited as an incomplete recessive trait,  and the 
heterozygote shows activity that is about half of nor-
mal activity.  Recently,  Japanese-type acatalasemia 
has been characterized by Takahara [4],  Ogata [19],  
Kishimoto [21] and Hirano [22]. In these reports,        
the Japanese type of acatalasemia is deﬁned as a 
hereditary or genetic metabolic disorder character-
ized by an almost total loss of catalase activity in 
erythrocytes and is inherited as an autosomal incom-
plete recessive trait,  and is often associated with 
progressive ulcerating oral gangrene.  In the charac-
terization of both Japanese and Swiss acatalasemia,  
an autosomal recessive trait can be used instead of an 
autosomal incomplete recessive trait,  in due consider-
ation of the fact that  heterozygote of Swiss acatalas-
emia was at the level of normal catalase activity in 
blood.  Dr. H.  Aebi also pointed out that acatalasemia 
cannot be considered a disease,  since all of acatalas-
emc subjects show a high level of activities; thus it is 
suitable to consider it an anomaly (abnormality) [7].  
Residual catalase presents in Japanese and Swiss 
acatalasemias, and the catalase activity is 0.08～0.67ｵ 
(0.34±0.21ｵ) of normal in Japanese acatalasemia,  
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0.5～2.0ｵ(0.18±0.1ｵ) of normal in Swiss acatalas-     
emia,  and 4.0ｵ and 6.7ｵ of normal in Hungarian 
acatalasemia A. Góth described Hungarian acatalase-
mia as an inherited pattern for acatalasemia,  in which 
less than 10ｵ of normal erythrocyte catalase activity 
was observed,  and inherited autosomal recessive trait.  
Acatalasemia is in a homozygote state and is distrib-
uted heterozygous condition [13].  Deﬁnition of 
human acatalasemia also adopted in mouse [23] and 
beagle dog acatalasemias considering genetic abnor-
mality.  The residual blood catalase activity of mouse 
Csb was 1.8ｵ of normal activity and that in the beagle 
dog was 0.7ｵ as determined by UV spectrophotome-
try [18].
　 2. Hypocatalasemia. Some of the family mem-
bers of acatalasemia,  including acatalasemia I con-
ﬁrmed by genetic study [21],  were found to have 
about half of the normal catalase activity and were 
diagnosed as hypocatalasemia. Family hypocatalase-  
mia is heterozygous and in a carrier state of acatalas-
emia [4].  Kishimoto et al.  ﬁrst reported that the 
DNA of a hypocatalasemic patient had a normal frag-
ment and a mutant fragment of the catalase gene [21].  
Hypocatalasemia (heterozygote) was reported in the 
family of Hungarian acatalasemia A [12,  13] and the 
proband of Hungarian B,  C and D was found by 
genetic study.  The hypocatalasemia was also found in 
13 of 22 subjects in 2 Peruvian acatalasemic subjects 
in a family [14] and 15 of 23 subjects in an Iranian-
born Jewish acatalasemic family [16].  The frequency 
of hypocatalasemia in far-eastern populations is as 
follows: In a Japanese population it was 0.25ｵ,  in a 
Ryukyuan population it was 0.007ｵ,  among Koreans in 
Japan it was 1.29ｵ (11/922) and among Chinese in 
Taiwan it was 0.33ｵ [6].  The gene ﬂow was esti-
mated by the frequency of hypocatalasemia.  
Heterozygote hypocatalasemias were also detected in 
mice and beagle dogs.  The frequency of heterozygotes 
was estimated to be 0.17ｵ in Japan [24] as calculated 
by Kimuraʼs formula [26],  which nearly coincides 
with the value (0.23ｵ) obtained by the screening.  
From 1947 to 1977,  90 cases of acatalasemia in 45 
Japanese families were reported [6].  In the following 
description of mammalian (human and nonhuman) 
acatalasemia,  acatalasemia is classiﬁed into the order 
referred to  each constituent part of the bioinformat-
ics [27].  The data obtained are summarized in 
Tables 1,  2 and 3. The data of human acatalasemia 
are summarized in Table 1 and 2 and those of nonhu-
man acatalasemia are Table 3.
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Table 1　 Bioinformatics of human acatalasemia; mutation of catalase gene.
Bio 
informatics
Japanese acatalasemia Hungarian acatalasemia Swiss 
acatal.
Type I Type II Type A Type B Type C Type D
Genome 
①Mutation of 
nucleotide
splicing 
mutation 
(G to A 
substitut.)
frame shift
mutation 
(T deletion)
frame shift 
mutation
(GA 
insertion)
frame shift 
mutation
(G 
insertion)
splicing 
mutation 
(G to T 
substitut.)
coding region 
mutation 
(G to A 
substitut.)
nd
②Position pos. 5 of 
intron 4
358(n) 
in exon 4 
TGA 43(＋n)＊
138(n) 
in exon 2 
TGA134(a)
79(n) 
in exon 2 
TGA 58(a)
pos. 5 of 
intron 7
pos. 5 of 
exon 9
nd
③Predicted 
change in 
peptide chain
no change termination
introduced 
at 133 Aa♯
termination
introduced
at 133 Aa
termination
introduced
at 57 Aa
no change Arg354 to His＊＊ nd
④Pred. change 
in protein
no change 
(normal)
truncated 
protein
truncated 
protein
truncated 
protein
decreased 
pr. in hyp.
aberrant 
protein
aberrant
protein＊＊＊
Note.  acatal.,  acatalasemia; Genome: ① nd,  not determined; A,  adenine; G,  guanine; T,  thymine; Substi or substitut.,  substitution;
② pos.,  position; (n),  nucleotide position; (a),  amino acid position; TGA,  TGA stop codon; Arg,  arginine; His,  histidine; ③ Aa,  amino 
acid; Aa♯.,  frameshift 119ﾝ133 Aa is estimated [22].  ④ Pred.,  predicted; pr., protein; hyp.,  hypocatalasemia; (＋n)＊.,  Nucleotide num-
ber in downstream from T delition; His＊＊., His is described in the reference [13]; however, the substitution from arginine to cysteine is               
also described in the reference [32].  aberrant protein＊＊＊.,  aberrant protein predicted from data of Table 2.
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Mutation of Catalase Gene (genome)
　 1. Japanese acatalasemia. Two types of muta-
tion were found in the acatalasemia.
　 1) Japanese acatalasemia I: (1) Casual or novel       
mutation site of catalase gene: Japanese acatalasemia 
I: Molecular defect in Japanese acatalasemia was ﬁrst 
reported in 1990 [28] by the Japanese acatalasemia 
group (Wen,  Osumi and Hashimoto in Shinshu Univ.  
School of Med.  and Ogata in Okayama Univ.  Med.  
School).  The guanine to adenine substitution at the 
ﬁfth position of intron 4 inhibited the correct splicing 
of the RNA product (one kind of the splicing mutation),  
which is considered responsible for the defective cata-
lase synthesis in acatalasemic individuals.  This report 
is the ﬁrst report of causal gene mutation in human 
acatalasemia.
　 (2) Conformation of splicing site: The mutant cata-      
lase gene from a typical Japanese acatalasemia was 
cloned.  The nucleotide sequence of the catalase gene 
was determined and compared with the sequence from 
a normal catalase gene.  Seven base diﬀerences were 
found between the normal and acatalasemic genes.  
Among them the guanine to adenine substitution at the 
ﬁfth position of intron 4 seemed most likely to be 
responsible for defective catalase synthesis in 
Japanese acatalasemia.  To conﬁrm this,  a chimeric 
gene was constructed in which a segment of the normal 
or acatalasemic catalase gene,  encompassing the 3ʼ 
part of exon 4,  the entire intron 4 and the 5ʼ portion 
of exon 5,  was contained within the third exon of 
human ｸ-globin gene.  When this chimeric gene con-
struct was introduced into simian virus-40-
transformed simian cells (COS-7),  the normal cata-
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Table 2　 Bioinformatics of human acatalasemia; eﬀect of mutation on elements of bioinformatics.
Bio- 
informatics
Japanese acatalasemia Hungarian acatalasemia
Swiss a.
Type I Type II Type A Type B Type C Type D
①Tran- 
scriptome 
(mRNA)
udc nd nd nd nd nd nor.
level
②Proteome 
(Blood) 
Cat. act (A/N)
0.6% ＜0.05% 4.0 and 
6.7%
52.2% 
(hypocatala-
semics)
60.6%＊ 
(hypocatala-
semics)
53.7% 
(hypocatala-
semics)
0.1～
1.3%
Heat stability stable nd unstable nd nd nd unstable
pI normal nd normal nd nd nd nd
Subunit size ca 60 kDa 
of normal
nd nd nd nd nd nd
③Xeno-
metabolome 
H2O2 applicat.
nd H2O2 appli.
increased
MetHb
nd nd nd nd nd
④Phenome＊＊ history of 
Alv. Pyorr.
history of 
laryngial 
cancer
DM. in 
acatala-
semics
DM＊＊＊ 
increased in  
cat. def.
families
type 2 
DM. 
at 35 Y 
(proband)
　not 
describ.
Note.  Swiss a.,  Swiss acatalasemia.; ① udc,  under detectable concentration.; nd,  not determined; nor.  level,  normal level; ② Cat.  act.  
(A/N),  catalase activity (acatalasemic activity/normal activity); pI.,  isoelectric point; ③ appli.,  application; MetHb.,  methemoglobin; ④ 
Alv.  Pyorr.,  alveolar pyorrhea (chronic marginal peridentis); DM.,  diabetes mellitus; def.,  deﬁcient.,  Y,  years old.
The 60.6%＊, decreased level of catalase protein is also examined by Western blot analysis. Phenome＊＊, the patients with WAGR including      
Wilms tumor usually have accompanying hypocatalasemia [19].  
DM＊＊＊,  an increased frequency of diabetes (12.7%) is detected in the Hungarian acatalasemic and hypocatalasemic family members than 
in the normocatalasemic ones (0.0%) [13,  30,  32].
Sections of Bioinformatics.  Genome in Table 1. and ①Transcriptome ②Proteome ③Metabolome and ④Phenome in Table 2.
Reference: Jap.  Ⅰ[19,  21,  28,  36,  41,  42],  Jap.  Ⅱ [22],  Swiss [7,  37],  Hungarian [11―13,  20,  29―32] by Góth.
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lase/ｸ-globin chimeric gene was spliced correctly as 
revealed on Northern blotting and RNA mapping.  In 
contrast,  the splicing of the acatalasemic chimeric 
pre-mRNA suggested that one entire exon sequence 
was skipped.  Thus the guanine-to-adenine substitution 
at the ﬁfth position of intron 4 of the catalase gene 
prevents the correct splicing of the RNA product.  
The same splicing mutation was found in the genomic 
DNA of another case of acatalasemia from an unre-
lated family.  Acatalasemic subjects showing the same 
splicing mutation as Wen et al.  [28] reported subse-
quently with the same female acatalasemic subject 
described by Kishimoto et al.  in 1992 [21] using the 
single-strand conformation polymorphism analysis of 
polymerase chain reaction (PCR-SSCP analysis).  The 
acatalasemic subjects used to their study were the 
previously examined acatalasemic female (Okayama 
Prefecture) and her brother who exhibits hypocatala-
semia and unrelated cases of acatalasemia from two 
other unrelated acatalasemic subjects (Hiroshima 
Prefecture and Kagawa Prefecture) who lived in the 
western part of Japan.  Results studied show the same 
splicing mutation.  They suggested a single mutated 
allele has spread in the Japanese acatalasemic popula-
tion.  These acatalasemic cases caused by the mutation 
are classiﬁed as Japanese typeⅠacatalasemia, pre-
349Mammalian AcatalasemiaDecember 2008
Table 3　 Bioinformatics of non-human acatalasemia
Animals MouseA (Csb) MouseH (Csc) Beagle dog
①Genome
Mutation of nucleotide
substitution G→T
(CAG→CAT)
substitution A→G
(AAT→AGT)
substitution G→A (979♯)
(GCT→ACT)
Predicted change in Aa Aa 11 Gln→His Aa 439 Asn→Ser Aa 327. Ala→Thr
②Transcriptome
(m-RNA)
nd nd normal level
in reticulocytes
③Proteome (residual catalase) reticulocyte activity>
erythrocyte activity
nd reticulocyte activity>
erythrocyte activity
Activity, (A/N)% ♂ (2.4%), ♀ (1.1%) ♂ (20%), ♀ (16%) 0.7%
Heat stability＊ nd unstable unstable
pI, value pI: 6.3ﾝ7.2 (Nor. 5.0ﾝ6.0) nd nd
Subunit size nd nd 63kDa of monomer＊＊
Life span of catalase;
reticulocyte→erythrocyte
shorter nd shorter
④Metabolome and
-Xeno-metabolome
including prevention of
clatinogenic promotion
increased conc. MetHb
NO exp. Hb→MetHb.
Hg0exp.→accumulation
in central nerve
methanol→low met. r.
nd nd
⑤Phenome (cartinogenese etc) higher incidence of breast 
cancer is inhibited 
by vitamin E
nd occasional exhibiting
oral gangrene similar to
Takaharaʼs Disease
Note: nd.,  not determined; A.,  acatalasemia; H.,  hypocatalasemia.  ① 979♯ showing nucleotide position; Aa.,  Amino acid; Gln.,  
glutamine; Hist.,  histidine; Asn.,  asparagines; Ala.,  alanine; Ser., serine; Thr.,  threonine; ③ pI.,  isoelectric point; ④ exp.,  
exposure; low met.  r.,  low metabolic rate; (① Genome, acatalasemic animals indicated a single nucleotide substitution of base at the 
position within the catalase-encoding region).
Heat stability＊., stability of aberrant catalase in acatalasemic mice and beagle dog might be derived from substitution of a nucleotide in                    
exon.  monomer＊＊: subunit size of catalase indicates 63kDa as the monomer subunit [80], lncreased concent MetHb＊＊＊: concentration 
ratio of MetHb to Hb were 1.6±0.2% in Csb and 0.8±0.3% in Csa mice.
Refernce: Mouse A [23,  33].  Mouse H [23,  34],  Beagle dog [18,  35,  80].
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sumably.
　 The presence of residual catalase suggests that the        
splicing mutation of the catalase gene is of the leaky 
type.
　 2) Japanese acatalasemiaⅡ: An acatalasemia hav-    
ing another type of novel mutation was reported in 
1995 by Hirano et al.  [22],  in which a deletion of the 
358th thymine in exon 4 of the catalase gene was 
found in the acatalasemia.  The frame shift caused by 
the nucleotide deletion altered the downstream of the 
amino acid sequence and generated a new terminal 
codon TGA 43 bp 3ｾ to the mutation.  A truncated 
peptide chain consisting of 133 amino acid residues 
might be translated in patient tissue.  A truncated 
protein is expected to be extremely unstable and has 
almost no catalase activity.  This type of acatalasemia 
is presumably called Japanese acatalasemiaⅡof which 
1 acatalasemia and 4 hypocatalasemia have been 
reported.
　 2. Swiss acatalasemia. No study on mutation 
of the catalase gene has been reported.
　 3. Hungarian acatalasemia. Novel gene 
mutation and change in the structure of catalase pro-
tein are described as follows.  All data (the type A,  B,  
C and D of Hungarian acatalasemia) are described by 
Góth L et al.  [13,  29ﾝ32].
　 1) Type A: A GA insertion at nucleotide position        
138 (exon 2) increasing the repeat number from 4 to 
5.  This GA insertion caused a frame shift mutation 
with the amino acid sequence from position 68 to 133 
and generated a TGA at 134.  The trans-located pro-
tein lacked the essential amino acid of histidine 74 
[29],  which is required for binding hydrogen peroxide 
substrate.
　 The blood catalase activities of 2 acatalasemic       
sisters were 4.0ｵ (M. K.) and 6.7ｵ (J. K.) and 45.8ｵ 
for the 23 hypocatalasemics which were compared 
with 26 normocatalasemic family members [13]. 
　 2) Type B: Nucleotide sequence analysis showed a       
G insertion at position 79 in exon 2 [30].  This muta-
tion caused a frame shift in the amino acid sequence 
from 49 to 57,  and a TGA stop codon was generated 
at position 58.  This truncated protein is not able to 
enzymatic function of catalase.
　 The mean value of the blood catalase activities of         
3 hypocatalasemic family members was 52.2ｵ of the 
mean activity in 4 normocatalasemic family members 
[13,  30] or 60.1ｵ of reference value of blood cata-
lase activity [30].  The frequency of diabetes (12.7ｵ) 
is higher level in the catalase-deﬁcient family members 
than the normocatalasemic ones [13,  30].
　 3) Type C: The G to T substitution at position 5          
of intron 7,  indicating a splice site mutation [13,  31].  
The eﬀect of this mutation was conﬁrmed by Western 
blot analysis demonstrating a decreased level of cata-
lase protein.
　 The mean blood catalase activities of 7 hypocatala-       
semia was 60.6ｵ [(58.8 MU/L)/(96.9 MU/L)] of 
normocatalasemic family members [13].
　 4) Type D: The G to A mutation in position 5 of           
exon 9 changes the essential amino acid arginine354 
into histidine [13] or cysteine and may be responsible 
for the decreased catalase activity [13,  32]. The 
mean blood catalase activity of hypocatalasemia was 
53.7ｵ of normocatalasemic family members. All ana-
lytical methods were based on the PCR-SSCP [13].
　 4. Mouse acatalasemia (CSb) and homologous 
hypocatalasemia (CSc). Shaﬀer et al.  [33] 
described that catalase cDNA clone was isolated from 
normal mice (Csa) and Csb acatalasemic mouse straines,  
respectively.  Sequence analysis of these cDNAs 
revealed that nucleotide transversion (G→T) occurs in 
the third position of amino acid 11 (from glutamine to 
histidine) of the acatalasemic mouse catalase gene.  
This was suggested to be the catalase deﬁciency of the 
acatalasemic mouse.  Glutamine is located within a 
region that forms the ﬁrst major ｸ-helix in the amino-
terminal arm.  Wang et al.  at [34] reported that the 
mutant catalase cDNA from acatalasemic (Csb),  
homologous hypocatalasemic (Csc) and normal (Csa) 
mice were cloned and expressed in bacteria,  A novel 
missense mutation in homologous hypocatalasemic 
mouse catalase cDNA leads to amino acid substitution 
of asparagine (AAT) to serine (AGT) at amino acid 
position 439 of hypocatalasemic catalase.  The substi-
tution at this position may aﬀect the formation of the 
substrate channel leading to the heme group in the 
tetrametric catalase molecule,  resulting in the low 
catalase activity in the (Csc) mouse.
　 5. Beagle dog acatalasemia. Nakamura et al.  
[35] isolated full-length cDNA clones of acatalasemic 
dogs.  Comparison of the catalase nucleotide sequences 
of catalase cDNA between the normal and acatalas-
emic beagle dogs indicated a single nucleotide substi-
tution of G and A at position 979 within the catalase 
encoding region causing an amino acid substitution of 
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alanine (GCT) at amino acid 327 to threonine (ACT).
　 6. Classiﬁcation of acatalasemia. These 
results are summarized as follows; acatalasemia is 
presumably classiﬁed into ① splicing mutation (sub-
stitution of a nucleotide) of a nucleotide in the intron 
observed in Japanese acatalasemia I [28] and 
Hungarian acatalasemia type C [31].  ② point muta-
tion (substitution of a nucleotide etc.) and frame shift 
mutation in the coding region.  Mutation of the nucleo-
tide in the coding region of catalase mainly a frame 
shift caused by nucleotide deletion or insertion 
induced alternation of the amino acid sequence [22] 
which was observed in Japanese acatalasemia II [22] 
and Hungarian acatalasemia A [29] and B [30],  and 
point mutation (substitution of a nucleotide) of an exon 
was observed in Hungarian acatalasemia D [32].  
Mouse acatalasemia [33] or hypocatalasemia [34] and 
beagle dog acatalasemia [35] are caused by point 
mutation within the catalase encoding regions.
Catalase Messenger RNA (transcriptome)
　 1. Japanese acatalasemia I. The RNA was  
extracted from the cultured acatalasemic ﬁbroblasts 
and analyzed by Northern blotting.  Acatalasemic 
extract gave only an extremely faint band,  indicating 
severe reduction of catalase mRNA as reported by 
Wen et al,  in 1988 [36].  The results indicate the 
defective synthesis of catalase protein caused by the 
serious decrease in catalase mRNA.
　 2. Swiss acatalasemia. The ﬁbroblasts strain 
obtained from Swiss acatalasemia containing normal 
amounts of catalase mRNA was conformed by 
Northern-blot analysis.  Crawforld et al.  [37] sug-
gested that a structural mutation in the catalase gene 
is probably responsible for the inactivation of the 
enzyme in Swiss acatalasemia,  as estimated from the 
results of m-RNA in Northern blotting.
　 3. Mouse acatalasemia. The results sug-
gested nearly normal levels of mouse catalase m-RNA 
in acatalasemic mouse (Csb) [33].
　 4. Beagle dog acatalasemia. Total RNA 
samples of the reticulocyte fraction from normal and 
acatalasemic dogs served as materials.  The expressed 
level of catalase mRNA and its size,  in acatalasemic 
reticulocytes,  were not changed when compared with 
those in the normal beagle dog reticulocytes [35].
Physicochemical Nature of Residual Catalase 
in Acatalasemia (related to proteome)
　 1. Isolation of a minimal amount of residual 
catalase in Japanese acatalasemic blood.
　 1) Japanese acatalasemia: Separation of residual     
catalase was carried out by Sephdex Gﾝ100 column 
chromatography from hemolysates of 4 acatalasemic 
subjects [43] by the manometric method.  The frac-
tion comprising the ﬁrst peak of the catalase activity 
was residual catalase,  and the catalase like activity of 
MetHb-H2O2 compound from hemoglobin in the second 
peak was hemoglobin.  Residual catalase activity was 
observed in 4 acatalasemic subjects including a subject 
with acatalasemia I.  Crude catalase fractions of 
hemolysates obtained from acatalasemic subjects were 
also fractionated by DEAE column chromatography.  
The Hb fraction was eluted with 1mM sodium phos-
phate buﬀer (pH6.8),  and A and B fractions were 
obtained at a buﬀer concentration of 10mM and C 
fraction was at a buﬀer concentration of 100mM by 
Thorup [38].  Oxygen evolution from hydrogen per-
oxide by catalase was determined by oxygen electrode 
and manometer [39,  40].
　 2) Swiss acatalasemia: A complete separation of      
residual catalase and hemoglobin could be achieved by 
Sephadex G100 column chromatography as reported 
by Aebi [7].
　 3) Beagle dog acatalasemia: The residual catalase      
in the liver was isolated by a procedure including a 
Fracto gel EMD－DEAE column chromatography.
　 2. Properties of residual catalase.
　 1) Immunodiﬀusion and immunoelectrophoresis.   
　 (1) Japanese acatalasemia: Residual catalase    
protein in the erythrocytes from Japanese acatalase-
mia I was conﬁrmed by a double immunodiﬀusion test 
used human catalase antibody [40]. Immunoelectro-   
phoresis was also carried out on the crude catalase 
from the erythrocytes in Japanese acatalasemia against 
antihuman erythrocyte catalase rabbit serum.  The 
presence of catalase protein was observed [40].
　 (2) Swiss acatalasemia: Residual catalase protein     
was also conﬁrmed by double immunodiﬀusion [7].
　 2) Electrophoretic mobility of residual protein.     
　 (1) Japanese acatalasemia: After the separation     
of catalase in acetone extract of acatalasemic erythro-
cytes by electrophoresis in polyacrylamide gel contain-
ing starch,  the band showing catalase protein had the 
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same mobility as in normal one [39].
　 (2) Swiss acatalasemia: The results of polyacryl      
amide-starch-agar mixed gel-electrophoresis showed 
that the erythrocyte catalase of normal fractions was 
faster than that of acatalasemic fractions [9].  
However,  catalase in acatalasemic ﬁbroblasts has one 
weak band but possesses the same electrophoretic 
mobility as catalase in normal ﬁbroblasts on 12.5ｵ 
polyacrylamide gel under diﬀerent conditions of elec-
trophoresis by Crawford in 1988 [37].
　 (3) Hungarian acatalasemia: Electrophoretic   
mobility of catalase in the type A of acatalasemic M.K.  
case was indistinguishable from the normal enzyme 
[11].
　 3) Isoelectric point (pI) of residual catalase.      
　 (1) Japanese acatalasemia I:   
　 Hemolysate was separated into fractions A, B, and        
C by using the DEAE column of Thorup [38].  The 
catalase in the C fraction was subjected to isoelectric 
focusing (IEF) in agarose gel followed by electroblot-
ting and catalase activity staining [41] or by electrob-
lotting onto polyvinylidene dichloride membrane and 
immuno-enzymic detection and pI value was examined 
[42].  The pI.  of acatalasemic catalase in the C frac-
tion is identical to the pI of normal catalase in the C 
fraction.  The analyses of pI values in the A and B 
fractions of acatalasemic hemolysates gave results 
similar to those seen in the C fraction [41].  The pI 
values of residual catalase in the sonicated homoge-
nates in cultured skin ﬁbroblasts in Japanese acatala-
semia with history of alveolar pyorrhea also showed 
the same pI value of normal catalase by a similar 
analytical method [41].
　 (2) Hungarian acatalasemia: The isoelectric    
point (pI) of catalase in tissues from acatalasemia M. 
K.  was indistinguishable from that of the normal 
enzyme [11].
　 (3) Mouse acatalasemia: The pI values of cata-      
lase molecules in the A,  B,  and C fractions separated 
by DEAE column increased in the following order:
normal ＜hypocatalasemic＜ acatalasemic mouse blood    
in each fraction [41].
　 4) Subunit size:  
　 (1) Japanese acatalasemia I: The subunit size of       
residual catalase in the C fraction prepared from the 
hemolysates of acatalasemia was also found to be 
identical with that of the normal fraction,  corre-
sponding to a molecular weight of nearly 60 KDa on 
SDS-polyacrylamide gel followed by electroblotting 
and immunoenzymatic ampliﬁcation [42] in Table 2.
　 (2) Beagle dog acatalasemia: The SDS-PAGE of      
puriﬁed liver catalase from normal and acatalasemic 
dogs gave a band at molecular weight of 63 KDa as 
also shown in Table 3.
　 5) Heat (Thermal) stability:   
　 (1) Japanese acatalasemia: The heat stability of      
the erythrocyte catalase C fraction from DEAE col-
umn chromatography was tested before and after 
incubation at 55℃ for 60min, and the remaining      
activity was tested.  As a result,  the heat stability of 
residual catalase in the Japanese acatalasemia tested 
showed no distinct diﬀerence from normal catalase 
[40,  43,  44],  suggesting that presence of trace 
amounts of m-RNA of normal catalase trace m-RNA of 
normal catalase.
　 (2) Swiss acatalasemia: In the C fraction of       
Swiss acatalasemia,  the remaining activity was 25ｵ 
of the original activity at 55℃ for 60min, indicating    
less heat stability than in the Japanese case [9,  10,  
43,  44].
　 (3) Hungarian acatalasemia: During incubation    
at 25℃ for a 6-h study on the hemolysates of the type           
A of acatalasemia (M.K.),  catalase activity in hemoly-
sates showed higher instability than normal [11].
　 (4) Mouse hypocatalasemia: In the residual cata-     
lase in hemolysates of mouse hypocatalasemia Csc,  
thermal stability was less stable than in normal mice 
Csa [23].
　 (5) Beagle dog acatalasemia: Recombinant cata-    
lase molecules in COSﾝ1 cells of normal and acatalas-     
emic dogs were tested.  Thermal stability of catalase 
in COS cells was examined in recombinant catalase of 
normal and acatalasemic beagle dogs in COSﾝ1 cells 
at 45℃ and it was found that over expressed acata-        
lasemic catalase in COS cells decreased rapidly when 
compared with that of normal dog catalase,  showing 
the lower heat stability of the acatalasemic catalase 
than normal catalase [35]. Heat stability of aberrant 
catalase protein in acatalasemic mice and beagle dog 
might be originated in substitution of a nucleotide in 
coding regions of catalase.
　 6) Aﬃnity toward the substrate of residual cata-       
lase (Michaelis constant).
　 Japanese acatalasemia: Normal and residual cata-    
lase molecules were separated by Sephadex Gﾝ100 in 
the hemolysates and the Michaelis constants (Km) were 
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found to be 0.35 and 0.37mM,  respectively.  The 
results measured were suggested that residual catalase 
activity in acatalasemia due to splice site mutation 
might not change at the region of the amino acid 
sequence in the active centers or ion pockets of cata-
lase molecules by the Michaelis constant [43].
　 7) Immunotitration: Speciﬁc catalase activity of     
Japanese acatalasemia I as determined by immunoti-
tration will be the same as normal catalase described 
by Ogata and Fujii [45].
Level and Distribution of Residual Catalase in 
the Blood and Solid Organs
　 1. Level of catalase activity in blood of acata-
lasemia and hypocatalasemia.
　 In the splicing mutation of the leaky type, minute         
amounts of residual catalase having properties of 
normal catalase might be biosynthesized.  In the muta-
tion of the cording region of catalase,  the frame shift 
mainly caused by the nucleotide deletion or insertion 
should alter the downstream amino acids sequence and 
a truncated peptide chain might be translated into 
aberrant acatalasemic protein [22].  Structural change 
of residual catalase might be caused by one point 
mutation of an exon like Hungarian acatalasemia D.  
Mouse acatalasemia also originated in one point muta-
tion.
　 1) Japanese acatalasemia: The catalase activities     
in the blood of acatalasemic subjects in 5 families and 
the ratio of this activity to normal activity were as 
follows: ①Gio Family: 19.20Pu/gHb,  (0.60ｵ of 
normal); ②Min Family: 17.01 (0.53ｵ); ③Sus 
Family: 4.75 (0.25ｵ); ④Miy Family: Mean,  5.4 
(0.17ｵ); and ⑤NAK Family 8.94 (0.28ｵ).  The 
mean of the 5 families measured by perborate methods 
was 11.02±6.72Pu/gHb (0.34±0.21ｵ) expressed as 
(m±SD),  and the range of measured values was 4.57
～21.52Pu/gHb (0.14～0.70ｵ) [39]. Members of 3      
families (Sus,  Miy and Nak) suﬀered from typical 
Takaharaʼs disease,  while a member of one family 
having acatalasemia I has a history of alveolar pyor-
rhea.  The residual catalase activity of an individual 
with acatalasemia I was 0.602ｵ of normal (3190Pu/
gHb) [39].  Heterozygote hypocatalasemia showed 
activity that was 44.9±12.1ｵ of normal.  There was 
almost no overlapping of catalase activity between the 
normal group (5.04±0.68,  Kcat) and the hypocatalas-
emia group (2.24±0.41,  Kcat) by the permanganate 
titration method.  The critical point was calculated to 
be 3.29 Kcat [43].
　 2) Swiss acatalasemia: The catalase activity in the       
blood was 0.10～1.3ｵ of the activity of normal sub-
jects [7] as determined by the perborate method 
[17].  The average catalase activity of hypocatalase-
mia amounted to 2.46±0.51 (m±SD) mg catalase/
gHb,  and the normal activity was 2.50±0.62mg cata-
lase/gHb.  Distinguishing between the normal subjects 
and heterozygote hypocatalasemia by catalase activity 
is not possible [10].
　 3) Hungarian acatalasemia: ①In type A (GA inser-
tion in exon 2) acatalasemias,  catalase activity was 4.0 
and 6.7ｵ of the normocatalasemic families as mea-
sured in the substrate of hydrogen peroxide by the 
spectrophotometric method and reported by Góth [11,  
29].  Truncated protein caused by the results of GA 
insertion lakes a histidine at position 74 in active 
center resulted in low catalase activities.  Further-
more,  ②In type B,  3 hypocatalasemic family mem-
bers showed activity that was 60.1±5.2ｵ of normal 
activity 113.3±16.5,  MU/l) or 52.2ｵ of the activity 
in a normocatalasemic family members (68.1MU/
L/130.4MU/L) ×100.  Truncated protein with its 58 
amino acid is not able to maintain the enzyme function 
of catalase [30].  ③In type C,  hypocatalasemia (60.6
±11.9) ｵ of the activity of normocatalsemic family 
members (58.5MU/L)/(96.9MU/L) ×100 was 
observed A G to C substitution was detected at posi-
tion 5 of intron 7 Decreased catalase protein caused 
by the eﬀect of splice site mutation was conﬁrmed by 
Western blot analysis [31],  and ④In type D,  53.7±
7.3ｵ of normocatalasemic (103.6MU/l) family mem-
bers was observed due to a G to A substitution at 
position of exon 9. The type 2 diabetes mellitus was 
observed at a relatively early age in the 35ﾝyear-old 
proband as reported by Góth [32].
　 4) Other human hypocatalasemia: Hypocatala-   
semia [Heterozygote] was recognized in Korean [6],  
Peruvian [14],  German [15] and Jewish [16] popu-
lations.  Hypocatalasemia can be found with a simple 
determination of the catalase activity in the blood 
without using gene analysis.  The catalase activity in 
the blood of Korean and Peruvian hypocatalasemia is 
similar to that of Japanese hypocatalasemia.
　 5) Mouse acatalasemia: Residual catalase activity     
was found to be 2.0ｵ of normal by the perborate 
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method at 37℃ for 5 minutes and 4.4ｵ of normal at 
20℃ by Tottori [52].  The residual catalase activity 
of acatalasemia (Csb) was 1.8ｵ and activity of hypo-
catalasemia was 18.0ｵ (mean of activity of male and 
female mice),  which was calculated from the report of 
Feinstein [46] by perborate method (37℃,  5min.).
　 6) Beagle dog: Residual catalase activity was found       
to be 0.7ｵ of the normal value using the spectropho-
tometric method for measuring hydrogen peroxide of 
the substrate [18].
Cellular Distribution of Residual Catalase  
Activity in Mature and Immature Red Cells
　 The results obtained were related to the life span         
of residual catalase in blood.
　 1. The residual catalase in erythrocytes and 
reticulocytes.
　 1) Human acatalasemia: In the blood of acatalas-      
emic subjects,  the reticulocyte rich and poor fractions 
were separated by 20ｵ albumin density gradient 
centrifugation,  and the number of reticulocytes and the 
catalase activity in the fractions were measured by 
Aebi [9].
　 (1) Japanese acatalasemia: The residual catalase     
activity in the blood was nearly equally distributed 
between reticulocytes and erythrocytes in 3 acatalas-
emia cases in one family and in one acatalasemia case 
in another family [43].
　 (2) Swiss acatalasemia: In 3 Swiss acatalasemic      
subjects,  residual catalase activity in the reticulo-
cytes and erythrocytes may diﬀer by a ratio of up to 
about 300: 1,  suggesting that residual catalase has a 
shorter life span than normal catalase [44].
　 2) Non-human acatalasemia: Animals made anemic     
condition by injection with phenyl hydrazine hydro-
chloride,  and the reticulocyte rich fractions were 
obtained.
　 (1) Mouse acatalasemia: Blood catalase: The    
change in the catalase activity as assessed by the 
perborate method [46] during the maturation of 
reticulocytes was measured both in normal conditions 
and in anemic condition induced by phenyl hydrazine 
and the catalase activity and reticulocyte counts were 
measured.  The results indicated that the catalase 
activity per reticulocyte in the blood of acatalasemic 
mice was 55ｵ of that of normal mice.  The degrada-
tion rate,  expressed as (catalase activity in reticulo-
cytes－catalase activity in erythrocytes)/catalase 
activity in reticulocytes,  was 88ｵ in the acatalasemic 
mice and 34ｵ in the normal mice,  respectively.  Thus 
the catalase activity in the erythrocytes of acatalas-
emic subjects was 10ｵ of the activity in the erythro-
cytes of normal mice [47,  48].
　 (2) Beagle dog acatalasemia: Dogs were made      
anemic by injection of phenyl hydrazine hydrochloride,  
and a reticulocyte-rich fraction was prepared.  Pulse 
labeling using 35S methionine and immunoprecipitation 
examination indicated that catalase synthesized in the 
acatalasemic dog was almost the same as that in the 
reticulocytes,  but the synthesized mutant catalase in 
the acatalasemia was degraded more rapidly than 
normal catalase.  The degradation was almost com-
pletely inhibited by lactcystin,  a proteasome speciﬁc 
inhibitor.  Nakamura suggested that degradation by the 
proteasome was most likely involved [35].  These 
reports suggested that the degradation of mutant cata-
lase with structural change was faster than that of 
normal catalase in Swiss acatalasemia and mouse and 
Beagle dog acatalasemias.
Distribution and Turnover of Residual 
Catalase in Acatalasemic Solid Organs
　 1. Distribution of catalase activity in solid 
organs of acatalasemia.
　 In order to determine the lifespan of residual cata-
lase and the ability to protect against oxygen stress in 
the solid organs,  the distribution of catalase in organs 
was studied.
　 1) Japanese acatalasemia.  
　 (1) Case 1: catalase activities in the liver,  muscle 
and bone marrow blood were not recognized under 
detectable sensitivity (USD) by Eulerʼs titration 
method [49] in one case of acatalasemia (2 of 4 sib-
lings in the family are acatalasemic subjects) [50].
　 (2) Case 2: The ratio of residual catalase activity 
to normal catalase activity in organs was 0.4ｵ in 
blood as determined by the permanganate method.  
Activity in the vermiform appendix was found to be 
2.7ｵ of normal,  Activity in the abdominal mussel 
could not be measured by Eulerʼs method 
[49].　Blood catalase activity was under the detect-
able level in Eulerʼs method.  In this acatalasemic 
family,  4 subjects with acatalasemia,  1 with hypo-
catalasemia and 1 normal subject were found among 9 
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siblings.  The above-mentioned acatalasemic individu-
als of one case and other 3 cases of acatalasemia might 
have similar organ distributions of catalase activity 
[51].
　 (3) Case 3: The ratio of residual catalase activity 
to normal catalase activity in organs was 37.9ｵ in the 
liver,  31.0ｵ in the small intestine,  30.2ｵ in the 
large intestine and 4ｵ in the blood [4].  In members 
of her family who were tested,  minute catalase activ-
ity was not found,  and hypocatalasemia was found in 
one of her nephews by the manometric method.  She 
has an atypical family tree.  She suﬀered from maxil-
lary cancer [4].
　 2) Swiss acatalasemia: Catalase activity in the     
blood of acatalasemic subjects was 0.1～1.3ｵ of nor-  
mal catalase activity in the liver was less than 0.1 
units per mg protein,  indicating almost no catalase 
activity [7].  Activity in the liver of hypocatalasemic 
subjects was between normal activity and that in 
acatalasemia.  Residual catalase activities in the lim-
phoepithel tissue and in the ﬁbroblasts of acatalasemia 
were 3ｵ and 2～3ｵ of normal, respectively (PU/    
mg. pr.) [7].
　 3) Hungarian acatalasemia. The ratios of the spe-      
ciﬁc catalase activity of each organ in acatalasemic 
subjects to that of each corresponding organ in normal 
subjects were 15.2ｵ for the liver,  12.4ｵ for the 
pancreas 13.0ｵ for the kidney,  13.5ｵ for the lung 
15.4ｵ for the spleen and 5.0ｵ for the blood,  indi-
cating less activity in blood than in solid organs.  
These results were calculated from the report as 
described by Góth [12] in Hungarian acatalasemia-A.
　 4) Mouse acatalasemia: Distribution in organs:   
Feinstein recognized higher activities in acatalasemic 
solid organs than in blood [46].  Tottori reported the 
activities in the solid organs measured by perborate 
assay at 20℃ for 5 minutes to avoid heat inactivation 
at 37℃ [52].  The ratios of catalase activity (PU/
mg. pr.) in the organs of acatalasemic subjects to 
activity in the organs of normal subjects were 65.9ｵ 
of normal in the liver,  15.6ｵ in the kidney,  69.9ｵ in 
the lung,  33.7ｵ in the stomach,  30ｵ in the brain,  
31.8ｵ in the heart and about 4.3ｵ in the blood.  
Similar results were described using a diﬀerent assay 
method by Wang et al. [53].
　 5) Beagle dog acatalasemia: The ratios of catalase       
activity in the organs of acatalasemic beagle dogs to 
the activity in normal dogs were 71ｵ in the liver,  
41ｵ in the kidney,  83ｵ in the intestine,  90ｵ in the 
heart,  56ｵ in the lung,  76ｵ in the pancreas,  35ｵ 
in the spleen,  100ｵ in muscle and 52ｵ in the brain 
[35].  The catalase activities of the solid organs of 
normal and acatalasemic mice were compared activites 
of solid organs of normal and acatalasemic dog.  
Relatively lower activity in the brain was found in the 
solid organs of normal and acatalasemic mice and also 
normal and acatalasemic beagles.
　 2. Synthesis and degradation of residual 
catalase in the acatalasemic mouse liver. The 
recovery of catalase activity after inhibition with 
aminotriazole in acatalasemic mice was determined 
[54].  The kinetics of catalase synthesis and degrada-
tion were determined in acatalasemic and normal liver 
catalase during the recovery of catalase activity after 
the activity was inhibited with aminotriazole in acata-
lasemic and normal mice singly.  The liver catalase 
turned over with a half-life of 10.0h in acatalasemic 
mice and a half-life of 19.2h in normal mice.  The 
results indicated that acatalasemic liver catalase was 
found to have a shorter life span.  The rate of catalase 
(Ks) was 0.168 (Pu/mg protein/hr) in acatalasemic 
mice and 0.271 in normal mice.  On the other hand,  the 
rate of catalase degradation (Kd) was 0.069 in acata-
lasemic mouse liver and 0.036 in normal mouse liver.  
It seems that the rate of catalase synthesis was lower 
and the rate of degradation was higher in acatalasemic 
mouse liver than in normal mouse liver,  thus giving 
rise to lower catalase activity in the livers of acatalas-
emic mice than in the livers of normal mice [54].  The 
synthesizing activity of catalase in the mouse liver was 
measured by 14C- leucine incorporation.  The results 
suggested that the incorporation activity of 14C- leu-
cine into catalase protein in acatalasemic mouse liver 
was lower than the incorporation activity into catalase 
protein in normal mouse liver [55].
Erythrocyte Metabolism against Oxidation and 
Related Enzyme (related to metabolome)
　 1. Superoxide dismutase and glutathione 
peroxidase. Hydrogen peroxide is generated by 
oxygen reduction of various oxidases.  Superoxide 
anion generated in cells may be converted to hydrogen 
peroxide by superoxide dismutase (SOD).  Hydrogen 
peroxide is decomposed by residual catalase and glu-
tathione peroxidase [6] in the acatalasemic blood.  
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However,  when the amounts of hydrogen peroxide 
generated by microorganisms and/or environmental 
chemicals exceeds the ability to decompose hydrogen 
peroxide,  cell damage will be produced [3,  6].  The 
levels of residual catalase were examined in 5 
Japanese acatalasemic families having 0.14～0.70ｵ of  
normal catalase activity in the blood [6,  54].  The 
leukocyte catalase activity was extremely low (0.13ｵ) 
in acatalasemia [56].  Assays of SOD activities were 
carried out by Beauchamp and Fridcvich [6,  57],  and 
the activities of glutathione peroxidase were deter-
mined in the blood of 5 Japanese acatalasemic families 
[6,  58].  The SOD activities of normal controls were 
49.1±7.8U/mgHb,  and those of 5 acatalasemic indi-
viduals fell in the range of 61.5±7.1U/mgHb.  The 
acatalasemic blood showed signiﬁcantly higher activity 
of superoxide dismutase than did the blood of normal 
subjects (p＜0.05).  Glutathione peroxidase activity in 
acatalasemic blood was shown to be slightly elevated 
compared with that of normal blood but within normal 
limits [6,  58].
　 The superoxide anion is considered to produce       
singlet oxygen and a hydroxyl radical in the presence 
of hydrogen peroxide by Harber and Weissʼs reaction:
　 O2－ ＋ H2O2→OH－ ＋OH.＋ 1O2.
　 It is supposed that the above reaction also occurs         
in acatalasemia.  However,  the superoxide anion in this 
reaction may be catalyzed by superoxide dismutase 
into hydrogen peroxide,  2O2－ ＋ 2H＋ →O2＋ H2O2,  
which is then decomposed with minimal catalase and 
glutathione peroxidase [6].  The activity of glucose-6-
dehydrogenase (G6PD) in erythrocytes in the subjects 
of 3 acatalasemic family was not signiﬁcantly diﬀerent 
between normal,  hypocatalasemia and acatalasemia in 
3 families of acatalasemia but in one family lower 
activity than normal was found in acatalasemia [56].  
The mean value of alkaline phosphatase activities in 
the plasma in an acatalasemic family was within the 
normal range [56].  One subject of acatalasemia I was 
found to show activitiies of lactate dehydrogenase in 
plasma and also AST and ALT in serum were within 
the normal range respectively.  The activity of catalase 
in the leucocytes was half of normal in hypocatalase-
mia and extremely low in acatalasemia [56].  The 
activity of residual catalase in the blood of subjects 
with acatalasemia I was very low and the activity of 
G6PD was within the normal range [58].
　 2. Methemoglobin. Methemoglobin (MetHb) 
concentration in Japanese acatalasemia is considered 
to have a tendency to be higher than in normal 
Japanese subjects,  but the diﬀerence between normal 
and acatalasemic subjects tested was small and could 
not be determined with because the MetHb level ﬂuc-
tuated every day.  MetHb concentration for Hb con-
centration in the blood of wild-type and mutant mice,  
as in the order of female acatalasemic mice,  male 
acatalasemic mice,  female homozygous hypocatalas-
emic mice and normal mice [59],  which is considered 
to be related to endogenous metabolism.
Eﬀect of Environmental Chemicals on Japanese 
Acatalasemia and Mouse Acatalasemia 
(belong genetic toxicology and also belonging 
Xeno-metabolome)
　 1. Genetic toxicology. The term genetic toxi-
cology or toxicogenetics (related to the ﬁeld of phar-
macogenetics) was ﬁrst used by Ogata in the textbook 
of Biological Monitoring of Exposure to Industrial 
Chemicals [60].  The investigation of the eﬀect of 
environmental chemicals on a deﬁcient metabolic 
enzyme system,  known as genetic toxicology or toxi-
cogenetics,  can lead to an understanding of the enzy-
matic reaction involving hazardous chemicals and of 
the experimental eﬀect of toxic environmental chemi-
cals on genetic diseases.  In one example of such 
investigation,  MetHb reductase deﬁciency or acatala-
semia was found to increase in concentration after 
exposure to MetHb inducer [60].
　 The eﬀect of environmental chemicals on acatalas-
emic subjects is described as follows:
　 1) Exposure of acatalasemic human blood and       
acatalasemic mice to nitrogen monoxide (NO) or nitro-
gen dioxide (NO2): Methemoglobin (MetHb) formed in 
the blood of human and mouse acatalasemic subjects 
exposed to NO or NO2 according to the following 
equation.
　 2NO2＋H2O＝2H＋NO2－＋NO3－ (1) 　　　 
　 Hb(O2)4＋2NO2－＋6H＋→
　 MetHb＋2NO3－＋H2O2＋2H2O＋O2 (2)… [61]
　 The reaction of hemoglobin and hydrogen peroxide       
produces ｍethemoglobin [62].
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　 A peroxidase action of catalase converts NO      2－to 
NO3－.
　 Thus, NO 2－and H2O2 decrease.
　 2NO2－＋H2O2→2H＋＋2NO3－ (3)…… [61] 
　 As for NO, it reacts with hemoglobin to form         
nitrosyl hemoglobin and nitrite as follows:
　 Hb(O2)4＋4NO→Hb(NO)4＋4O2 (4) and Hb(NO)4 
＋4O2→MetHb＋4NO3－ (5) and then Hb(NO)4＋
4NO3－→MetHb＋8NO2－ (6).  Thus nitrite ion and 
MetHb are produced.  The equation suggested that 
hydrogen peroxide participate these chain reactions.
　 (1) Erythrocyte exposure of Japanese and mouse       
acatalasemic blood to NO or NO2 (in vitro experi-
ment): Catalase activity in the blood of Japanese 
acatalasemia I was 0.6ｵ of normal activity [39].  No 
signiﬁcant diﬀerence in NADH MetHb reductase 
activity was found between Japanese acatalasemic 
blood and normal blood [63].  In normal and Japanese 
acatalasemic erythrocytes exposed to NO or NO2,  the 
concentrations of MetHb were larger in acatalasemic 
erythrocytes than normal erythrocytes [60,  63].  The 
ratios (ｵ) of MetHb to hemoglobin concentration in 
the acatalasemic erythrocytes exposed to 200ppm NO 
gas for 0,  30,  60 and 90 minutes were 0.72,  6.55±
0.41,  11.77±0.95 and 20.17±2.84ｵ,  respectively,  
and in normal erythrocytes for 0,  30,  60 and 90 min 
they were 1.03,  4.75±0.18,  8.81±0.72,  and 12.45
±1.11ｵ,  respectively.  MetHb concentration in 
Japanese acatalasemic erythrocytes was signiﬁcantly 
higher than in normal erythrocytes (p＜0.05; deter-
mined by t- test) for all of the above exposure times.  
Similar results were obtained with human erythro-
cytes exposed to NO2.
　 The levels of MetHb concentrations of normal and 
acatalasemic Japanese erythrocytes after exposure to 
NO were higher than after exposure to NO2 under the 
same exposure concentration.
　 (2) Acatalasemic mouse erythrocytes in vitro     
experiment: When acatalasemic mouse erythrocytes 
were exposed to 200ppm of NO,  the MetHb concen-
tration in the blood was signiﬁcantly higher than that 
in normal mice.  The results were similar to human 
erythrocytes exposed to 200ppm of NO2.
　 (3) Acatalasemic mice exposed to NO or NO       2,  in 
vivo experiment: The MetHb concentrations in the 
blood of acatalasemic mice exposed to 100ppm of NO 
for 0,  20,  40 and 60 minutes were 1.52±0.16,  
17.47±3.48,  25.49±5.06 and 31.58±2.04ｵ of total 
hemoglobin,  respectively,  and in normal mice they 
were 0.85±026, 10.63±3.75, 18.39±0.31 and 22.21
±2.72ｵ,  respectively.  In the entire range of studied 
concentrations of NO,  the mean concentrations of 
MetHb in the blood of acatalasemic mice were higher 
than in the blood of normal mice.  Similar results on 
MetHb formation were obtained after exposing mice to 
NO2,  although the rate of MetHb formation was lower 
in the blood of NO-exposed mice [60,  62].
　 (4) Inhibitory eﬀect of αtocopherol on MetHb       
formation: MetHb formation in both normal and acat-
alasemic mouse hemolysates exposed to 180ppm of 
nitrogen oxide was signiﬁcantly inhibited by the addi-
tion of ｸ-tocopherol [64].  The formation of MetHb in 
acatalasemic mouse hemolysates exposed to nitrogen 
oxide was greater than that in normal hemolysates 
with or without the addition ofαtocophenol [64].
　 (5) MetHb formation in Japanese acatalasemia by       
hydrogen peroxide: In a study by Hamada et al. [65],  
the oral cavity and larynx of an acatalasemic patient 
were disinfected with 300ml of a 1: 2 dilution of 3ｵ 
hydrogen peroxide,  then 11ｵ MetHb concentrations 
were recognized.  The patient was given ascorbic acid 
intravenously after medical treatment,  and the MetHb 
concentration decreased to 7.5ｵ.  The MetHb concen-
tration on postoperative day 3 then became normal 
(0.5ｵ).
　 2. Hemolysates and mouse exposure to metal-
lic mercury. 1) Japanese acatalasemic hemoly-
sates: Normal and acatalasemic hemolysates from 
Japanese subjects were exposed to metallic mercury.  
The amount of mercuric ions taken up by human 
acatalasemic erythrocytes was less than that taken up 
by normal erythrocytes with or without hydrogen 
peroxide.  The data indicated that erythrocyte catalase 
oxidizes metallic mercury to mercuric ions through its 
peroxidative action [66].  Deisseroth et al.  [67] con-
sidered that the oxidation of metallic mercury by cata-
lase might be a chain reaction in which ferric ions 
react with hydrogen peroxide to form Fe3＋OOH,  
which oxidizes metallic mercury to mercuric oxide.  
Fe3＋OH＋H2O2→Fe3＋OOH＋H2O and Fe3＋OOH＋
Hg0→Fe3＋OH＋HgO
　 2) Mice exposed to metallic mercury vapor:      
Mercury distribution in mouse organs was studied 
after normal and acatalasemic mice underwent mer-
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cury vapor exposure.  The concentration of metallic 
mercury in the arterial blood of acatalasemic mice is 
higher than in that of normal mice.  The mercury 
concentration and the organ/blood rate of mercury 
concentration in the brain,  liver,  placenta and fetuses 
in acatalasemic mice are higher than those in normal 
mice.  The rate of the mercury level in the brain to 
that in the blood of acatalasemic mice was about 2 
times higher than that of the normal mice.  These 
observations suggest that lipid soluble metallic mer-
cury passes the blood-brain barrier and the blood-
placenta barrier more easily in acatalasemic mice than 
in normal mice [68ﾝ70].
　 3. Acatalasemic mice injected with methanol.
The amount of [14C] carbon dioxide exhaled by acata-
lasemic and normal mice (Csb) injected with [14C] 
methanol or [14C] formic acid is less than that exhaled 
by acatalasemic mice,  suggesting that catalase plays a 
major role in murine metabolism for methanol [71].
　 4. Carbon tetrachloride. After a single intra-
peritoneal injection of carbon tetrachloride to acata-
lasemic mice (Csb),  centrilobular necrosis in the livers 
of Csb mice was historically more severe than that in 
normal mice.  The liver malondialdehyde level in 
acatalasemic mice was nearly two-fold higher than that 
in normal mice at 18h after CCl4 treatment [72].  The 
carbon-tetrachloride-induced liver injury in acatalas-
emic mice is inhibited by hepatic iron deprivation 
[73],  indicating that the formation of active oxygen as 
in hydrogen peroxide or hydroxyl radicals formed 
from hydrogen peroxide might be related to CCl4-
induced hepatotoxicity.
　 5. Prevention of carcinogenesis promotion.
　 1) Mammary tumor: C3H females,  both Csa and 
Csb,  carrying the MuMTV eventually showed essen-
tially a 100ｵ incidence of mammary tumor [74].  
Female acatalasemic and hypocatalasemic mice had an 
increased incidence of spontaneous mammary tumors.  
The cumulative incidence of spontaneous mammary 
tumor in vitamin E-supplemented acatalasemic mice   
(47ｵ) was signiﬁcantly lower than in vitamin-E-
deprived mice (82ｵ).  Thus,  vitamin E might be use-
ful for tumor prevention [75].
　 2) Liver tumor: ①Administration of aminotriazole     
(AT) C3H mice are also a strain with a high natural 
incidence of liver tumors [74].  The eﬀect of pro-
longed mouse diet on liver tumor appearance in normal 
and acatalasemic C3H mice was tested.  A large pro-
portion (21/87) of the acatalasemic group developed 
liver tumors than did the normal catalase mice,  and 
they were detected earlier (beginning at 35 weeks) 
[74].  ②Administration of diethylnitrosamine (DEN):
Acatalasemic mice (C3H/AnLCsb) were more suscep-
tible to DEN,  leading to enhanced hepato-
cartinogemesis in comparison with normal mice [76].
Escherichia coli Incorporated Mouse  
Acatalasemic Gene
　 In order to clarify whether the reactive oxygen        
species are involved in hydroquinone-induced cytotox-
icity,  E. coli strains that express murine catalase 
derived from catalase (Csb and Csc)　and wild-type Csa 
in catalase-deﬁcient E. coli UM255.  Hydroquinone 
toxicity was examined using a zone-inhibited test,  and 
UM255 showed the largest inhibition zone,  followed 
by Csb,  Csc and Csa.  The results suggest that hydro-
gen peroxide is involved in hydroquinone-induced 
cytotoxicity in a catalase-deﬁcient E. coli mutant [77].
Catalase Gene Mutation and Disease Reported 
(included in the phenome)
　 1. Takaharaʼs disease. (1) Occurrence of 
Takaharaʼs disease: In human acatalasemia,  about 
41ｵ of Japanese actatalasemia,  a Peruvian acatalas-
emia (1979) and a German acatalasemia (1999) have 
been associated with the oral progressive gangrene 
known as Takaharaʼs disease.  The pathogenesis of the 
oral gangrene can be explained as follows.  Some 
germs,  pneumococcus and ｹ-streptcoccus,  exist in 
crevices of teeth produce hydrogen peroxide.  In 
Japanese acatalasemia,  hydrogen peroxide is not 
decomposed and will destroy hemoglobin in the blood,  
resulting in local malnutrition and the development of 
the gangrenous disease [4].  Peruvian acatalasemia (n
＝2) and German acatalasemia with Takaharaʼs disease 
were reported by Delgado WA et al. [14] and Pemer 
H et al. [15],  respectively.  Swiss acatalasemia with-
out Takaharaʼs disease was reported by Aebi et al. in 
[7].  Hungarian acatalasemia without Takaharaʼs dis-
ease and higher prevalence rates of diabetes mellitus 
was reported by Góth L in 1992 [11].
　 (2) Trend of occurrence of Takaharaʼs disease:      
The incidence rate of Takaharaʼs disease in Japanese 
acatalasemic individuals from 1945 to 1955 was 0.68 
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(17/25),  and from 1956 to 1970,  it was 0.27 (13/49).  
The diﬀerence between the rates is signiﬁcant (p
＜0.001) [78].  A yearly decrease in incidence 
through the improvement of nutritional conditions and 
oral hygiene and also the use of antibiotics were con-
sidered to be a possible cause for the diﬀerence.  The 
means by which acatalasemia was found included sur-
gical operation (23.3ｵ),  Takaharaʼs disease (24.4ｵ) 
and survey of hypocatalasemia (52.3ｵ) [79].  
Acatalasemic beagle dogs occasionally exhibit an oral 
gangrenous disease very similar to Takaharaʼs disease 
[80].
　 2. Diabetes mellitus. In the report by Góth 
[32],  a proband of Hungarian acatalasemia of type D 
developed type 2 diabetes mellitus at a relatively early 
age (35 years).  The frequency of diabetes in the cata-
lase deﬁcient family members was (12.7ｵ) which was 
higher than normocatalasemic family members (0.0ｵ) 
[13, 30] Góth described that increased hydrogen 
peroxide levels may damage oxidative-sensitive β cells 
in the pancreas and decrease insulin production.  The 
exact mechanisms by which hydrogen peroxide aﬀects 
pancreatic function/insulin production are still 
unknown [13].
　 3. Wilms tumor- anirida, genitourinary 
abnormalities and mental retardation triad.
The patients with this condition (WAGR) caused by 
chromosomal deletion in 11p 13 usually accompany 
with hypocatalasemia [19].
Bioinformatics of Japanese Acatalasemia I
　 Studies of acatalasemia I demonstrated the follow-      
ing; ① splicing mutation (leaky type) [28], ② pre-       
mRNA [28] (appropriate amounts) and mRNA (under 
the detectable concentration) [36],  ③ residual cata-
lase (0.60ｵ of normal activity [39],  with pI and 
subunit size at the normal level) [41,  42] and ④ his-
tory of alveolar pyorrhea [81].
　 The sections describing acatalasemia I in this       
manuscript concerned the conﬁrmed cases.  The 
Japanese acatalasemic subjects examined almost lived 
in the Okayama acatalasemia I.
Acknowledgments.　The authors are grateful to the late Prof. Sigeo         
Takahara at Okayama University for his guidance in this study.  The 
authors express our thanks to Prof.  Takashi Hashimoto and Assistant 
Professor Takashi Osumi of Shinshuu University for their constant 
leadership in the studies of genetic biochemistry.  The authors have pro-
vided no information on sources of funding or on conﬂicts that are rele-
vant to the content of this review.
References
 1. Kirkman HN and Gaetani GF: Mammalian catalase,  a venerable 
enzyme with mysteries.  Trends in Bioochem Sci (2006) 32: 44ﾝ50.
 2. Takahara S and Miyamoto H: Clinical and experimental studies on 
the odontogenous progressive necrotic ostitis due to lack of blood 
catalase.  Nihon Jibiinnkouka Gatsukai (J Otorrhi Soc) (1948) 
51: 163ﾝ164 (in Japanese).
 3. Takahara S: Progressive oral gangrene probably due to lack of 
catalase in the blood acatalasemia; Report of nine cases.  Lancet 
(1952) 2: 1101ﾝ1104.
 4. Takahara S: Acatalasemia in Japan; in Hereditary disorder of 
erythrocyte metabolism,  Beutler E ed,  Grune and Shantton,  New 
York (1968) pp 21ﾝ40.
 5. Takahara S,  Hamilton HB,  Neel JV,  Kobara TY,  Ogura Y and 
Nishimura ET: Hypocatalasemia: A new genetic carrier state.  J 
Clin Invest (1960) 39: 610ﾝ619.
 6. Takahara S and Ogata M: Metabolism of acatalasemia with spe-
ciﬁc reference to superoxide dismutase and glutathione peroxidase.  
Biochemical and Medical Aspects of Active Oxygene.  Hayaishi O 
and Asada K eds,  University Tokyo Press,  Tokyo (1977) pp 275ﾝ
292.
 7. Aebi H,  Bonggiolini M,  Deward B,  Lauber E,  Suter H,  Micheli A 
and Frei J: Observation in Swiss families with acatalasemia. II.  
Enzymol Biol Clin (Basel) (1964) 4: 121ﾝ151.
 8. Aebi H and Cants M: Uber die cellukarre Verteiling der Katalase 
im Blut Homozygoter und Heterozygotes (Akatalasia).  Human-
genetik (1966) 3: 50ﾝ60.
 9. Aebi H,  Bossi E,  Cants M,  Matubara S and Suter H: Acatala-
semia in Switzerland; in Hereditary disorder of erythrocyte metabo-
lism.  Beutler E ed,  Grune and Shantton,  New York (1968) pp 41ﾝ
65.
10. Aebi H,  Wiss SR,  Sherz B and Gross J: Properties of erythrocyte 
catalase from homozygotes and heterozygotes for Swiss type acat-
alasemia.  Biochem Genet (1976) 14: 791ﾝ807.
11. Góth L: Characterization of acatalasemia detected in two 
Hungarian sisters.  Enzyme (1992) 46: 252ﾝ258.
12. Góth L: Two cases of acatalasemia in Hungary.  Clin Chem Acta 
(1992) 207: 155ﾝ158.
13. Góth L,  Rass P and Pay A: Catalase Enzyme Mutation and their 
Association with Diseases.  Mol Diagn (2004) 8: 141ﾝ149.
14. Delgado WA and Calderón R: Acatalasemia in two Peruvian sib-
lings.  J Oral Pathology (1979) 8: 358ﾝ368.
15. Pemer H,  Krenkel C,  Lacker B,  Hintner H and Hawranek T:
AkatalasämieﾝMorbus Takahara.  Hautarzt (1999) 50: 590ﾝ592.
16. Szeinberg A,  De Vries A,  Pinkhas J,  Djaldetti and Ezra R: A dual 
hereditary red cells defect in one family: Hypocatalasemia and 
glucoseﾝ6ﾝphospate dehydrogenase deﬁciency.  Geneticac et 
Gemellogiac (1963) 12: 247ﾝ255.
17. Feinstein RN,  Seaholm JE,  Hopward JB and Russell WL:
Acatalaemic mouse.  Proc Natl Acad Sci USA (1964) 52: 661ﾝ
662.
18. Fukuda K,  Shindo H,  Yamasita K and Mizuhira V: Catalase activ-
ity of erythrocytes from beagle dog: an appearance of hereditary 
acatalasemia.  Acta Histochem Cytochem (1982) 15: 685ﾝ690.
19. Ogata M: Acatalasemia.  Hum Genet (1991) 86: 331ﾝ340.
20. Góth L: New type of inherited catalase deﬁciencies: Characteriza-
359Mammalian AcatalasemiaDecember 2008
15
Ogata et al.: Mammalian Acatalasemia: The Perspectives of Bioinformatics and Ge
Produced by The Berkeley Electronic Press, 2008
tion and comparison to the Japanese and Swiss type of acatalase-
mia.  Blood Cells Mol Dis (2001) 27: 512ﾝ517.
21. Kishimoto Y,  Murakami Y,  Hayashi K,  Takahara S,  Sugimura T 
and Sekiya T: Detection of a common mutation of catalase gene 
in Japanese acatalasemic patients.  Hum Genet (1992) 88: 487ﾝ
90.
22. Hirono A,  Sasaya-Hamada F,  Kanno H,  Fujii H,  Yoshida T and 
Miwa S: A Novel Human Catalase Mutation (358ﾝdel) causing 
Japanese-type Acatalasemia.  Blood Cells.  Mol Dis (1995) 21: 232
ﾝ234.
23. Feinstein RN,  Howard JB,  Braun JT and Seaholm JE:
Acatalaemic and hypocatlasemic mouse mutants.  Genetics (1966) 
53: 923ﾝ933.
24. Takahara S,  Ogura Y,  Masuda Y,  Nishioka K,  Nishizaki K,  
Sugiura T,  Furukawa K,  Mizuko Y,  Kuroda Y, Ogata M and 
Ohkura K: Field Servey of acatalasemia and hypocatalasemia.  
Okayama Igakkai Zasshi (JOMA) (1986) 98 : 577ﾝ586 (in 
Japanese).
25. Ogata M,  Hayashi S and Takahara S: Estimation of the frequency 
of recessive gene of acatalasemia.  Acta Med Okayama (1971) 
25: 193ﾝ198.
26. Kimura M: Theoreticccal basis for the study of inbreeding in man.  
Jinrui Idenn Gakukaishi (Jpn J Hum Genetics) (1958) 3: 51ﾝ70 (in 
Japanese).
27. Mount DW: Bioinformatics: Sequence and Genome Analysis,  2nd 
ED,  Cold Spring Harber.  New York (1970).
28. Wen JK,  Osumi T,  Hashimoto T and Ogata M: Molecular analysis 
of human acatalasemia: Identiﬁcation of splicing mutation.  J Mol 
Biol (1990) 211: 383ﾝ393.
29. Góth L,  Shemirani A and Kalmar T: A novel catalalase mutation (a 
GA Insertion) causes the Hungarian Type of Acatalasemia.  Blood 
Cells Mol Dis (2000) 26: 151ﾝ154.
30. Góth L: A novel catalase mutation (a G insertion in exson 2) 
causes the type B of the Hungarian acatalasemia.  Clin Chim Acta 
(2001) 311: 161ﾝ163.
31. Góth L,  Rass P and Madarasi l: A novel catalase mutation 
detected by polymerase chain reaction-single strand conformation 
polymorphism,  nucleotide sequencing,  and Western blot analyses 
in responsible for the type C of Hungarian acatalasemia.  Electro-
phoresis (2001) 22: 49ﾝ51.
32. Góth L,  Vitai M,  Rass P,  Sukei E and Pay A: Detection of a 
novel familial catalase mutation (Hungarian type D) and the possi-
ble risk of inherited catalase deﬁciency for diabetes mellitus.  
Electrophoresis (2005) 26: 1646ﾝ1649.
33. Shaﬀer JB and Preston KE: Molecular analysis of an acatalasemic 
mouse mutant.  Biochem Biophys Res Commun (1990) 173: 1043ﾝ
1050.
34. Wang DH,  Tsutsui K,  Seno K,  Masuoka N and Kira S: cDNA 
cloning and expression of mutant catalase from the hypocatalas-
emic mouse,  comparison with the acatalasemic mutant.  Biochim 
Biophys Acta (2001) 1522: 217ﾝ220.
35. Nakamura K,  Watanabe M, tanaka K,  Sasaki Y and Ikeda T:
cDNA cloning of mutant catalase in acatalasemic beagle dog: sin-
gle nucleotide substitution leading to thermal-instability and 
enhanced proteolysis of mutant enzyme.  Int J Biochem Cell Biol 
(2000) 32: 1183ﾝ1193.
36. Wen JK,  Osumi T,  Hashimoto T and Ogata M: Diminished syn-
thesis of catalase decrease in catalase mRNA in Japanese-type 
acatalasemia.  Physiol Chem Phys Med NMR (1988) 20: 171ﾝ176.
37. Crawford DR,  Mirault ME,  Moret R,  Zbinden IR and Cerutti PA:
Molecular Defect in human acatalasemia Fibroblast.  Biochem 
Biophys (1988) 153: 59ﾝ66.
38. Thorup OA Jr and Carpenter JT and Howard P: Human erythrocyte 
catalase: Demonstration of heterogeneity and relationship to eryth-
rocytes among aging in vitro.  Br J Haematol (1964) 10: 542ﾝ550.
39. Ogata and Mizugaki J: Properties of residual catalase in the eryth-
rocytes of Japanese-type of acatalasemia.  Hum Genet (1979) 
48: 329ﾝ338.
40. Ogata M and Mizugaki J: Residual catalase in Japanese type 
acatalasemia.  Cell Struct.  Func (1978) 3: 279ﾝ29.
41. Ogata M and Satoh Y: Isoelectric focusing of catalase from acata-
lasemic mouse and human blood and cultured human skin ﬁbro-
blasts.  Electrophoresis (1988) 9: 128ﾝ131.
42. Ogata M,  Suzuki K and Satoh Y: Characterization of human resid-
ual catalase of an acatalasemic patient by isoelectric focusing and 
sodium dodecyl-polyacrylamide gel electrophoresis followed by 
electrophoretic blotting and immunodetectin.  Electrophoresis 
(1989) 10: 194ﾝ198.
43. Ogata M,  Tomokuni K,  Watanabe S,  Osaki H,  Sadamoto M and 
Takahara S: Residual catalase in the blood of Japanese acatalas-
emia.  Tohoku J Exp Med (1972) 107: 105ﾝ114.
44. Matubara S,  Suter H and Aebi H: Fractionation of erythrocyte cat-
alase from normal,  hypocatalasemic and acatalasemic human.  
Humangenetik (1967) 4: 29ﾝ41.
45. Ogata M and Fujii Y: Immunotitration of the catalase in the blood 
of Japanese subject and mice suﬀering from acatalasemia and 
hypocatalasemia.  Physiol Chem Phys Med NMR (1992) 24: 261ﾝ
262.
46. Feinstein RN,  Braun JT and Howard JB: Acatalasenemic and 
hypocatalasemic mouse mutants.  II.  Mutational variations in blood 
and solid tissue catalases.  Arch Biochem and Biophys (1967) 
120: 165ﾝ169.
47. Ogata M,  Inoue T,  Tomokuni T and Takahara S: Catalase activity 
of immature and mature red cells of mouse acatalasemia.  Acta 
Haematol (1970) 44: 11ﾝ20.
48. Iden M: Activities of catalase protein in immature and mature red 
cells of acatalasemic mouse mutants.  Okayama Igakkai Zasshi 
(JOMA) (1990) 102: 789ﾝ798 (in Japanese).
49. Euler HV and Josephson K: Catalase I.  Justus Liebigs Ann Chem 
(1927) 452: 158ﾝ181.
50. Yoshiya M: “Aenzymeia of catalasemia” a new type of constitu-
tional abnormality,  Koukuubyou Gakukai Zatsusi (Jpn J Dis Oral 
Cavity) (1952) 19: 18ﾝ25 (in Japanese).
51. Ogata M,  Mizugaki J and Takahara S: Catalase activity in the 
organ of Japanese acatalasemia.  Tohoku J Exp Med (1974) 
113: 239ﾝ243.
52. Tottori Y: Activity and stability of catalase in the organ of acata-
lasemic mice －comparison of activities at diﬀerent incubating 
temperature by the perborate method: Okayama Igakkai Zasshi 
(JOMA) (1987) 99: 1623ﾝ1632 (in Japanese).
53. Wang DH,  Masuoka N and Kira S: Animal model for oxidative 
stress research-Catalase mutant mice.  Environ Health Prev Med 
(2003) 8: 37ﾝ40.
54. Ogata M,  Mizugaki J and Takahara S: Recovery of catalase activ-
ity after inhibition with aminotriazole in acatalasemia mice.  Tohoku 
J Exp Med (1975) 116: 39ﾝ43.
55. Ogata M,  Yakagi M,  Ogata K,  Tomoluni K,  Mizugaki T and 
Takahara S: Change of speciﬁc activity of catalase in acatalas-
emic mouse liver.  Tohoku J Exp Med (1974) 114: 349ﾝ354.
56. Ogata M,  Mizugaki J,  Taketa K and Takahara S: Activities of cat-
alase in leucocytes and glucose- 6-phosphate dehydrogenase in 
erythrocytes of hypocatalasemia and acatalasemia: Tohoku J Exp 
360 Acta Med.  Okayama　Vol. 62, No. 6   Ogata et al.
16
Acta Medica Okayama, Vol. 62 [2008], Iss. 6, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol62/iss6/1
Med (1977) 122: 93ﾝ97.
57. Beauchamp C,  and Fridovich I: Superoxide dismutase,  Improved 
assays and an assay applicable to acrylamide gels.  Anal Biochem 
(1971) 44: 267ﾝ287.
58. Ogata M,  Mizugaki J,  Ueda K and Ikeda M: Activities of superox-
ide superoxidase and glutathione peroxidase in the red cells of 
Japanese acatalasemia blood.  Tohoku J Exp Med (1977) 123: 95ﾝ
98.
59. Ogata M,  Kobayashi H,  Ioku N and Ishii K: Methemoglobin con-
centration in the blood of acatalasemic mice.  Proc Japan Acad 
Ser B (1986) 62: 367ﾝ371.
60. Ogata M and Megro T: Eﬀect of enzyme deﬁciency on biological 
exposure monitoring,  A toxigoenetic study of acatalasemia.  
Thomas V and Ogata M eds,  Biological study of exposure to 
industrial Chemicals,  ACGIH , Cincinnati (1990) pp 149ﾝ150.
61. Tomoda A,  Tuji A and Yoneyama Y: Involvement of anion in the 
reaction mechanism of oxidation of hemoglobin by nitrate.  
Biochem J (1981) 193: 169ﾝ179.
62. Orita Y: On the degradation of oxyhemoglobin in acatalasemic 
hemolysates.  Jinrui Iden Gakukkai Shi (Jpn J Human Genetics) 
(1962) 7: 163ﾝ189 (in Japanese).
63. Ogata M,  Ishii K and Meguro T: Methemoglobin formation in the 
blood of Japanese subjects and mice from acatalasemia in 
response to methemoglobin inducers.  Physiol Chem Phys Med 
NMR (1990) 22: 125ﾝ134.
64. Zen LX,  Ishii K,  Taketa K and Ogata M: Inhibitory eﬀect of ｸ
-tocophenol on methemoglobin formation by nitric oxide in normal 
and acatalasemic mouse hemolysates.  Physiol Chem Phys Med 
NMR (1993) 25: 253ﾝ260.
65. Hamada Y,  Kameyama Y,  Iizuka T,  Ishizaki T,  Nishiyama T and 
Isshiki A: Methemoglobinemia from hydrogen peroxide in a patient 
with acatalasemia.  Anestheology: (2004) 101: 247ﾝ248.
66. Ogata M,  Ikeda M and Sugata Y: In vitro mercury uptake by 
human acatalasemic erythrocytes.  Arch Environ Health (1979) 
34: 218ﾝ221.
67. Deisseroth A and Dounce A: Catalase: Physiological and chemi-
cal properties,  Mechanism of catalysis and physiological role.  
Physiol Rev (1970) 50: 319ﾝ375.
68. Ogata M and Ikeda M: Mercury uptake by acatalasema mice and 
their erythrocytes and lung and liver homogenates.  Int Arch Occup 
and Environ Health (1978) 41: 87ﾝ93.
69. Ogata M and Aikoh H: Mechanism of metallic mercury oxidation in 
vitro by catalase and peroxidase.  Biochem Pharmacol (1984) 
33: 490ﾝ493.
70. Ogata M and Meguro T: Fetal distribution of inhaled mercury vapor 
in normal and acatalasemic mice.  Physiol Chem Phys Med NMR 
(1986) 18: 165ﾝ170.
71. Karinje KU and Ogata M: Methanol metabolism in acatalasemic 
mice.  Physiol Chem Phys Med NMR (1991) 22: 193ﾝ198.
72. Wang DH,  Ishii K,  Zhen LX and Taketa K: Enhanced liver injury 
in acatalasemic mice following exposure to carbon tetrachloride.  
Arch Toxicol (1996) 70: 189ﾝ194.
73. Wang DH,  Ishii K and Taketa K: Inhibition of carbon tetrachloride 
induced liver injury in acatalasemic mice by hepatic iron depriva-
tion.  Hepatol Res (1998) 10: 237ﾝ247.
74. Feinstein RN,  Michael Fry RJ and Staﬀeldt EF: Carcinogenic and 
antitumor eﬀect of aminotriazole on acatalasemic and normal cata-
lase mice.  J Natl Cancer Inst (1978) 60: 1113ﾝ1116.
75. Ishii K,  Zen LX,  Wang DH and Taketa K: Prevention of mammary 
demureness in acatalasemic mice by vitamin E supplementation.  
Jpn J Cancer research (1996) 87: 680ﾝ684.
76. Wang DH,  Funamori Y,  Ikeda S,  Sato M,  Kira S and Taketa K:
Enhanced hepatocartinogenesis in acatalasemic mice treated with 
Diethylnitrosamine.  Hepatol Research (1998) 12: 217ﾝ224.
77. Horita M,  Wang DH,  Tsutsui K,  Sano K,  Masuoka N and Kira S:
Involvement of oxidative stress in hydroqunone-induced cytotoxicity 
in catalase-deﬁcient Escherichia coli mutants: Free Radic Res 
(2005) 39: 1035ﾝ1041.
78. Ogata M: Catalase and acatalasemia,  Ogata M ed,  Gakukai 
Shuppan Center,  Scientiﬁc Society Press,  Tokyo (1991) pp 65ﾝ66 
(in Japanese).
79. Takahara S,  Ogura Y,  Masuda Y,  Nishioka K,  Nishizaki,  K,  
Sugiura T,  Furukawa K,  Mizuno Y,  Kuroda Y,  Ogata M and 
Ohkura K: Field survey of acatalasemia and hypocatalasemia from 
1949 through 1985.  Okayama Igakkai Zasshi (JOMA) (1986) 
98: 577ﾝ586 (in Japanese).
80. Nakamura K,  Watanabe M,  Tanaka K,  Sasaki Y and Ikeda T:
Puriﬁcation and characterization of liver catalase in acatalasemic 
beagle dog: comparison with normal dog liver catalase.  Int J 
Biochem Cell Biol (2000) 32: 89ﾝ98.
81. Ogura Y,  Onoda M,  Sano K and Takahara M: Report on two fami-
lies of acatalasemia discovered in dental clinics.  Koukuu Byou 
Gaku Zasshi (1965) 32: 313ﾝ318 (in Japanese).
361Mammalian AcatalasemiaDecember 2008
17
Ogata et al.: Mammalian Acatalasemia: The Perspectives of Bioinformatics and Ge
Produced by The Berkeley Electronic Press, 2008
18
Acta Medica Okayama, Vol. 62 [2008], Iss. 6, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol62/iss6/1
